El acceso a la versión del editor puede requerir la suscripción del recurso Access to the published version may require subscription Cholesterol levels are strictly regulated to maintain its homeostasis therefore, if it is not 9 absorbed with the diet, the cholesterol biosynthetic pathway is enhanced and vice versa. 10
mushrooms extracts could be due to transcriptional and post-transcriptional modulations besides 23 other indirect effects. 24
Molecular events occurring during cholesterol absorption 95
Most of the micellated lipid-like compounds are incorporated into the organism through 96 the second part of small intestine (jejunum), except bile acids that can be absorbed at jejunum and 97 ileum levels by an apical sodium-dependent bile acid transporter (ASBT) 18, 19 . The SR-B1 scavenger 98 receptor (encoded by SCARB1 gen in humans) mainly located at both apical and basolateral 99 membranes 17, 20 of adrenal glands, hepatocytes and enterocytes (Figure 1 ), is involved in the 100 regulation of the endocrine metabolism, vitamin absorption or bile secretion. It also plays a role 101 in the cholesterol transport through membranes as a receptor of HDL (high-density lipoprotein)-102 cholesterol but not in the small intestine absorption context 20, 21 . SR-B1 transport allows a passive 103 bi-directional cholesterol efflux depending of concentration gradients 22 pointing SR-B1 as an 104 important modulator of reverse cholesterol transport (RCT) (described later) 20 . However, although 105 SR-B1 contribute to enterocytic cholesterol absorption, recent studies demonstrated that 106 intracellular cholesterol concentrations. At low cholesterol levels, SCAP (integral membrane 120 protein) goes along with SREBP2 from endoplasmic reticulum (ER) to Golgi body (GB) for 121 subsequent processing and activation. On contrary, at high or enough cholesterol levels SCAP-122 SREBP2 complex is retained by INSIG proteins (Insulin induced gene 1 protein located in ER 123 membrane) to avoid SREBP2 maturation impairing its transcription 25 . Moreover, other reports 124 pointed PPARδ (peroxisome-proliferator-activated receptor δ) as another NPC1L1 modulator 125 since down-regulation of the cholesterol transporter has been induced by PPARδ activation in 126 mice 11 . 127
Intracellular non-esterified cholesterol concentrations could also be modulated by ATP-128 7 Due to confusions noticed in several publications, it is worthy to define the specific role of 145 two widely mentioned enzymes involved in the transferring of acyl groups within the cholesterol 146 metabolism. Acetyl-Coenzime A transferase (ACAT) and Sterol O-acyltransferase (SOAT) are two 147 enzymes belonging to the acyltransferases family however, they do not catalyze the same reaction 148 (Table 1) . ACAT isoforms (ACAT1/ACAT2) are responsible of the reversible formation of 149 acetoacetyl-CoA from two molecules of acetyl-CoA. The ACAT1 and ACAT2 genes are respectively 150 located in chromosome 11 (11q22.3) and chromosome 6 (6q25.3) 30, 31 . However, SOAT isoforms 151 (SOAT1/SOAT2) catalyze the formation of fatty acid-cholesterol esters from cholesterol and acyl-152
CoA molecules and are encoded by two genes located respectively in loci 1q25.2 and 12q13.13 32, 33 . 153
Then, since some of the mentioned works along the text wrongly referred to ACAT when it should 154 indicate SOAT, a personal advice ( AvS mark) was made pointing attention where required. 155
Once non-esterified cholesterol reaches the cytoplasm become a substrate of ACAT2 (AvS) , 156 an integral membrane protein mainly expressed in small intestine and liver. ACAT2 (AvS) decreases 157 cytoplasmic amounts of non-esterified cholesterol promoting its esterification and integration 158 into the ER pre-chylomicrons modulating the cholesterol transmembrane absorption rate from 159 intestinal lumen 34 . It also plays an important role maintaining the dynamic equilibrium 160 (homeostasis) between free-cholesterol and esterified-cholesterol 35 . More than 50% of sterols 161 esterification within the enterocytes is carried out by ACAT2
(AvS) with a higher affinity for 162 cholesterol esterification rather than other non-cholesterol sterols. 163
The internal ER triglycerides re-assemblage is carried out by several enzymes such as 164 lysophosphatidate acyltransferase (AGPAT), phosphatidate phosphatase (LPAP), 2-acylglycerol O-165 acyltransferase 2 (MGAT2) and diacylglycerol O-acyltransferase 1 (DGAT1). Then, esterified-166 cholesterol together with the triglycerides is packed into pre-chylomicrons by the microsomal 167 triglyceride transfer protein (MTTP) and the apolipoprotein B48 (an isoform derived from APOB 168 gene characteristic of enterocytes). MTTP and APOB48 proteins constitute an active 169 heterodimeric complex linked by ionic interactions with a particular feedback assembly andsecretion system i.e. the larger the APOB48 subunit is, the lower binding capacity with MTTP is 171 noticed and less APOB48 is secreted. Therefore, the APOB48-MTTP binding process plays an 172 important role in the lipoprotein biogenesis [36] [37] [38] . 173
The combined regulatory effect of NPC1L1, ABCA1, ABCG5/8 and ACAT2
(AvS) activities play 174 a critical role in modulating the amount of esterified cholesterol that will be integrated in the pre-175 sterol reductase (DHCR24), farnesyl-diphosphate farnesyltransferase (FDFT1/SQS) or 7-196 dehydrocholesterol reductase (DHCR7), are also susceptible of modulation. Recently, Gill et al. 197 (2011) suggested that squalene monoxygenase (SQLE) might be the second critical modulatory 198 point despite its lower specificity within the cholesterol metabolism compared to HMGCR (after in 199 vitro experiments) 41 . 200
However, other enzymes such as SQS and SQLE are also gaining attention as a potential 201 stop-point of cholesterol biosynthesis because SQS it is involved in the transformation of farnesyl 202 pyrophosphate into squalene, being the first specific reaction at the branching point between 203 sterol and non-sterol biosynthesis. SQS transcriptional product and protein are modulated by 204 cholesterol since low levels of this sterol activate the SQS promoter by sterol regulatory element 205 binding proteins (mostly SREBP2). On the contrary, SQS mRNA concentration decreases as 206 response of cholesterol excess. SQLE is a monoxygenase (also named squalene epoxidase) that 207 catalyzes the next step after squalene transformation by SQS, a crucial oxygenation process 208
Molecular events occurring during cholesterol excretion 243
For several decades, classical reverse cholesterol transport (RCT) was considered the main 244 mechanism to eliminate cholesterol however, recent studies suggest another possible pathway 245 called transintestinal cholesterol excretion (TICE) 17 . 246
RCT is a derivative branch of the hepatobiliary pathway. Lipoproteins such as HDL or LDL 247 make available cholesterol for hepatic absorption as esterified or non-esterified molecules. 248
Esterified cholesterol is transformed by the hepatic cholesteryl ester hydrolase (NCEH1) into the 249 non-esterified form after hydrolysis of the ester linkage. Thus, the generated forms are directly 250 excreted through the ABCG8/5 heterodimer protein or transformed into bile salts 46 unwarranted balance between cholesterol inputs and outputs in mouse models. They showed a 263 higher amount of fecal cholesterol than the sum of dietary intake and biliary secretion 48 Moreover, esterified cholesterol of chylomicron structures is also recognized by LDLR providing to 305 the hepatocyte those cholesterol molecules assembled in enterocytic ER after digestion process. 306
The complex cholesterol biosynthesis and absorption enginery and the multifactorial 307 regulation system make the control of cholesterol metabolism a difficult challenge for the scientific 308 community. Particularly because some of the involved compounds are also intermediates of other 309 metabolic pathways i.e LXR modulates ABCG5/8 activity but also DIO1, a selenoprotein involved in 310 the thyroid hormone metabolism. However, these facts are also making it a flexible system that 311 could be modulated from different critical points. 312
3.
Fungal molecules modulating cholesterol metabolism
313
Many food compounds have been described as modulators of cholesterol homeostasis 314 interacting with specific control points and inhibiting or altering cholesterol metabolism; even 315 some in vivo studies suggest synergistic hypocholesterolaemic activities between several 316 inhibitors [57] [58] [59] . Those compounds showed different targets depending if they modulate cholesterolIntake of dietary fibers (DF) from cereals etc., increase cholesterol and bile acids excretion rates 319 lowering their bioavailability because they might act as bile acid scavengers. This mechanism 320 impair bile acids re-absorption stimulating the hepatic synthesis of new bile acids from cholesterol 321 reducing its blood concentration 10,60,61 although for particular β-glucans, modulation of 322 cholesterol-related gene expresions have been also noticed 62 . 323
Plant sterols (phytosterols and phytostanols) are considered direct cholesterol competitors 324 for their incorporation into DMMs because of their structural similarity and due to the limited 325 capacity of DMMs to solubilize lipophilic and water-insoluble molecules [63] [64] [65] . Some reports also 326 suggested that phytosterols might modulate SOAT activities although it still remains partially 327 unclear. Cholesterol enterocytic esterification by ACAT (AvS) was decreased by sterols competition 328 although the enzyme showed lower esterification efficiency for plant sterol than cholesterol. Other 329 authors suggested that plant sterols influenced MTTP and APOB48 lipoprotein in vitro models 65 . 330
Compounds such as novel amino β-lactams derivates 66 or curcuminoids polyphenols were 331 described as potential NPC1L1 inhibitiors by showing high binding affinity or acting by indirect 332 influence on SREBP1 37 . ABCG5/8 postranscriptional regulations were also described for 333 spironolactones or polyphenols from Aronia Melanocarpa 67, 68 . 334
Other compounds from natural sources have been reported as ACAT (AvS) inhibitors reducing 335 cholesterol esterification rates such as alkamides from Piper nigrum 69 , shikonin derivatives from 336
Lithospermum erythrorhizon 70 , an isoprenyl flavonoid identified as grabol from licorice roots 71 , 337 ursolic acid (indirect inhibition via (PPAR)-α activation) 72 or flucoxanthin from marine plants 73 . 338
3.1.

Hypocholesterolemic compounds of edible mushrooms 339
A few specific bioactive compounds are already pointed as responsible for the 340 hypocholesterolaemic properties of mushrooms. The most extensively investigated are fungal 341 sterols (ergosterol are its derivatives such as ergost-22-ene-1,3-diol, ergosta-5,7-dien-3b-ol, (22E)-342 ergosta-1,4,6,22-tetraen-3-one, etc.) and β-glucans together with other dietary fibres.
Ergosterol (ergosta-5,7,22-trien-3β-ol) is considered the major fungal sterol (from 53% up to 344 80% of the fungal sterols, w/w) followed by ergosterol derivatives such as ergosta-5,8,22-trien-3-345 ol, ergosta-7,22-dien-3-ol, ergosta-5,7dien-3-ol and ergosta-7-en-3-ol (fungisterol) 74 Apparently, the hypocholesterolaemic activities of fungal sterols were mainly due to their 352 structural similarity with cholesterol as noticed for plant sterols. Therefore, these compounds were 353 able to hinder cholesterol incorporation into DMMs as phytosterols and phytostanols. 354
Ergosterol-enriched fractions obtained using green technologies such as supercritical fluids 355 extraction (SFE), were more effective than β-sitosterol in displacing cholesterol from DMMs during 356
an in vitro digestion model 59 . Moreover, fungal sterol-enriched extracts also showed HMGCR 357 inhibitory activities in vitro 75 and ergosterol was also considered as a competitive inhibitor of C24-358 reductase due to its double bond at C-22 in the side chain of its structure (as also noticed for 359 stigmasterol and brasicasterol). The C24-reductase is another enzyme involved in the cholesterol 360 biosynthetic pathway down-stream from HMGCR 76 . 361 Fungal β-glucans showed different molecular structures than cereal polysaccharides. Their 362 branching profiles are (13) and (13)(16) conferring them many biological activities such as 363 antitumoral, antioxidant, immunomodulatory etc. despite hypocholesterolaemic properties 10, 77, 78 . 364 Some reports suggested that those bioactive properties are due to their different tridimensional 365 configuration depending on their monomer composition, branching degree or conformation while 366 other authors considered their water solubility (that is also partially dependent on their glycosidicpointed β-glucans degradation products (generated i.e. after a digestion process) as 370 hypocholesterolemic molecules more bioactive than their larger precursors 10,79 . However, until 371 now the precise structural requirements for the observed hypocholesterolemic action of fungal β-372 glucans remains unclear awaiting further studies. 373 β-Glucans from a large number of mushroom species have been studied such as lentinan from 374 shiitake mushrooms (Lentinula edodes), schizophyllan from Schizophyllum commune, grifolan from 375
Grifola frondosa, and many others from Agaricus blazei, Ganoderma lucidum (a medicinal 376 mushroom consumed as nutraceutical or dietary supplement), P. ostreatus as well as the (13) β-377 glucans and glucuronoxylomannans from Auricularia polytricha and Tremella fuciformis 80, 81 . They 378 all showed different conformations, solubility and therefore biological properties. 379
Chitin, a special type of water-insoluble β-(1→4)-glucan including N-acetylglucosamine 380 monomers, is also considered an hypocholesterolaemic polysaccharide while its derivative, named 381 chitosan, was more studied because of its antitumor and immunomodulation activities 10, 77 . Several 382 polysaccharide fractions (containing high percentages of fungal β-, α-glucans and 383 chitooligosacharides among others) from L. edodes, P. ostreatus and A. bisporus extracted by using 384 pressurized technologies (PSE) showed bile acid binding capacities in vitro similar to those shown 385 by cereals fibers 82 indicating that might impair cholesterol absorption as previously suggested for 386 plant β-glucans. 387 kinases phosphorylation. Their precise mechanism of action is still unclear but, it seems to involve 396 activation of regulatory factors such as PPAR 85, 86 . 397
Only a few compounds are still nowadays pointed as potential inhibitors of the SQS such 398 as resveratrol from wine 87 as well as zaragozic acids isolated from the liquid broth of certain 399 ascomicetes 100 . 400 24(S), 25-epoxycholesterol was also pointed as inhibitor of the DHCR24 activity. This 401 enzyme catalyze the transformation of desmosterol into cholesterol. The inhibitor did not modify 402 DHCR24 protein levels, but increased desmosterol accumulation decreasing cholesterol levels in 403 in vitro studies due to its structural similarity with desmosterol 88 . 404
Molecular events modulated by mushroom extracts 405
The presence of certain natural molecules in mushrooms do not only modify cholesterol 406 absorption or metabolic pathway of consumers but can also modulate the expression of some 407 genes related to cholesterol homeostasis. Recent studies carried out on particular edible 408 mushrooms studied their influence as attempt to further identify the most interesting fungal 409 compounds to treat moderate hypercholesterolemia. 410
Mushrooms such as Pleurotus ostreatus, Grifola frondosa and Hypsizigus marmoreus were 411 able of differently modulating the gene expression patterns of mice livers fed with each 412 mushroom (10-14%) for 4 weeks. Triglyceride levels in liver and plasma decreased in the mice fed 413 with P. ostreatus compared with those in the control group. Moreover, liver cholesterol decreased 414 while plasma total cholesterol increased probably due to HDL values that were also increased. 415
Cholesterol in the liver was lower in the group fed with G. grondosa than in the control group but 416 no changes were found in the H. Marmoreus-fed group. DNA microarrays analysis of the livers 417 revealed that CTP1A and FABP families were upregulated in the P. ostreatus-fed group, which 418 were considered to promote lipid transport and β-oxidation. In the G. frondosa-fed group, not 419 only the gene involved in signal transduction of innate immunity via TLR3 and interferon but also 420 virus resistance genes (such as MX1, RSAD2 and OAS1) were upregulated 89 . 421
Administration of Agaricus brasiliensis (also known as Agaricus blazei) to 422 hypercholesterolemic albino Fischer rats during 6 weeks lowered cholesterol levels in serum and 423 induced significant changes in the expression of cholesterol-related genes. HMGCR mRNA 424 expression was not influenced but LDLR upregulation was noticed together with upregulation of 425 CYP7A1, the rate-limiting enzyme for bile acid synthesis, and mRNA levels of the ABCG5/8 carriers. 426
These increases were accompanied by a significant increase in the content of cholesterol excreted 427 in the faces and by a concomitant increase in NR1H3 (LXR) mRNA levels. However, in this case 428 PPAR-α was not significantly upregulated compared with levels noticed in the 429 hypercholesterolemic control group 90 . 430
In a few reports specific extracts and not the whole fruiting body were studied. For instance, 431 ethanol (95%) extracts obtained from P. ostreatus were administrated to hypercholesterolemic 432
Male Wistar rats during 14 days and a reduction of triglycerides and HDL cholesterol was noticed 433 in plasma. Moreover, the extract was able of up regulate the genes that were downregulated after 434 hypercholesterolemia induction such as those related to fatty acids oxidation such as acyl CoA 435 oxidase (ACO) and synthetase (ACS) together with carnityl palmityl transferase-1 (CPT-1) and 436 PPAR-α. They also downregulated genes related to the fatty acids biosynthesis and cholesterol 437 metabolism (FAS fatty acid synthase, SREBF1, APOC3) to similar expression than during 438 normocholesterolemia 91 . 439
Hericium erinaceus hot water and ethanol extracts were administrated together with a high-440 fat diet to C57BL76J mice for 4 weeks. Incorporation of the extracts in the diet resulted in a 441 significant decrease in body weight, fat and serum and hepatic triglicerides levels compared to 442 control. The ethanol extract was acting as an agonist of PPAR-α since it was able of up-regulating 443 mRNAs usually modulated by PPAR-α (ACAT, ApoA1, LPL or SREBP1) in spite of the fact that the 444 PPAR-α expression itself did not change 92 . 445 An extract obtained from cauliflower mushroom (Sparassis crispa) significantly enhanceda cholesterol-rich diet for 4 weeks because they were able of up-regulating CYP7A1 mRNA 448 expression concomitant with HMGCR downregulation after. Additionally, the extract 449 supplementation resulted in cholesterol and bile acid fecal excretion 93 . 450
Molecular events modulated by fungal sterols 451
Since plant and fungal sterols share structural similarities, similar modulation of cholesterol 452 related genes might also be expected. However, in the few studies carried out using fungal sterols 453 different effects were noticed. 454
Ergosterol was able of regulating sterol regulatory element binding protein (SREBP) 455 cleavage in yeast as response to cellular oxygen levels 94 suggesting that it might also modulate 456 these elements in mammalians. Studies carried out using cell cultures revealed that DMMs isolated 457 from in vitro digestion of ergosterol and extracts containing ergosterol mixed with cholesterol were 458 not influencing transcriptional levels of SREBF1 differently than when only cholesterol was 459 administrated. Moreover, only a slight inhibition was noticed for SREBF2 mRNA of Caco2 cells when 460 treated with an ergosterol-containing extract but not with ergosterol itself. However, other 461 cholesterol related genes were also overexpressed such as the LDLR (when an ergosterol-enriched 462 extract from Agaricus bisporus was applied) 15 . When the lower compartment of the Caco2 cells 463 supplemented with the sterol-containing digested extracts were added to HepG2 cells, higher 464 modulation of genes related to the lipid metabolism was noticed than those more directly related 465 to the cholesterol homeostasis such as DGAT2 upregulation. 466
When similar extracts were given for 4 weeks to C57BL/6JRj mice previously fed for 4 467 weeks with hypercholesterolemic diets, inhibition of SREBF2 and NR1H4 (gene enconding FXR) 468 were noticed in jejunum up to similar levels than hypocholesterolemic drugs such as ezetimibe and 469 simvastatin 15 . This downregulation was due to their ergosterol content because supplementation 470 with purified ergosterol induced similar modulation. FXR is the farnesoid X receptor, a nuclear 471 receptor also involved in the regulation of cholesterol homeostasis 95 . FXR is involved in the 472 activation or inhibition of bile acids synthesis and transport acting as a sensor of theirconcentration 96 . The extract induced downregulation of DGAT2 in liver as observed in cell cultures 474 but upregulation of FDFT1, might be to compensate for the reduction on the ratio TC/HDL 475 recorded. Reduction on the triglycerides levels were also noticed in liver, perhaps because of the 476 observed modulation on DGAT2 gene transcription. Moreover, this extract induced overexpression 477 of DIO1 mRNA in jejunum, the tissue where cholesterol absorption is higher 97 . Type I iodothyronine 478 deiodinase is a selenoprotein encoded by DIO1 gene and play a major role in normal thyroid 479 function, but it is also indirectly influencing cholesterol homeostasis by regulating the LDLR gene 480 expression. Increased DIO1 activity in liver correlated with up-regulation of the LDLR mRNA and 481 lowering of TC, TG and LDL levels in serum 15 . However, no significant effect was noticed by Gil-482
Ramirez et al., 2015 97 on the latter gene, perhaps the supplemented concentration was sufficient 483 to stimulate DIO1 but it did not revert on LDLR readjustments. On the contrary, ergosterol 484 administrated as single compound induced downregulation of DIO1 mRNA therefore the effect of 485 the ergosterol enriched extract could be due to some other sterol or compound present in the 486 extract 97 . 487
However, when the ergosterol containing extracts were incorporated into lard and the 488 mixture supplemented together with the diet to induce hypercholesterolemia, insignificant effects 489 were noticed on any SREBP, other cholesterol regulatory nuclear receptor or genes involved in the 490 cholesterol metabolism except for ABCG5 and 8 mRNAs expression in cecum that were up-491 regulated. Perhaps the addition of the extract as ingredient inside a lipid matrix prevented their 492
proper bioavailability (because it was also unable of lowering cholesterol levels in serum, HDLc or 493 LDLc) or perhaps the beneficial properties of ergosterol were not sufficient to overcome the 494 detrimental effect of lard and the hypercholesterolemic diet when administrated simultaneously 98 . 495
Transcription of some ABC transporters (ABCG5/8 etc.) was induced by LXR factor in 496 enterocytes (but not in hepatocytes) 65 although, there is a controversy about its influence on other 497 transporters (ABCA1). Oxysterols such as 22(R)-hydroxycholesterol, 24(S),25-epoxycholesterol orsterols derivatives showed higher LXR agonist activity. Brasicasterols from unicellular algae and 500
Brassiceas sp (i.e. rapeseed) induced large variations in the gene expression of ABC transporters 501 due to their ability to act as the LXR factor in mice. Moreover, sitostanol (in mice), sitosterol (in 502
Caco2 cells) and a few 4-desmethylsterol derivatives were also able of inducing ABCA1 up-503 regulation using their LXR agonist activity 5, 11, 13, 65 . However, no direct effects of phytosterols or 504 fungal sterols were noticed on the transcriptional levels of the transporters because on the one 505 hand, in ABCA1 and ABCG5/8-deficient mice decreasing of cholesterol intestinal absorption was 506 also noticed after phytosterol administration indicating that ABC transporters were not their direct 507 targets. On the other hand, no significant overexpression or repression was neither noticed in 508 hypercholesterolemic C57BL/6JRj mice treated with ergosterol-containing extracts 15 . 509
Other reports indicated that phytosterol/stanols modulated HMGCR expression via 510 ACAT (AvS) inhibition. Apparently, lower ACAT (AvS) activity led to higher free cholesterol amounts, 511 inhibiting the cholesterol biosynthetic pathway and HMGCR expression beside others. It also 512 reduced chylomicron assembling, and promoted the back efflux of non-esterified sterols to the 513 lumen 11, 65, 99 . However, their influence on SOAT seemed to be by chemical inhibition more than by 514 molecular modulation. Direct down-regulation of HMGCR mRNA (together with inhibition of the 515 enzyme) was only noticed in organic extracts obtained from the Reishi mushroom (Ganoderma 516 lucidum) containing oxygenated lanosterol derivatives. They also inhibited cholesterol synthesis in 517 T9A4 hepatocytes and reduced total cholesterol in hamsters 100 . 518
Several in vitro studies pointed out that SREBP2, NPC1L1 and SR-B1 gene expression was 519 modulated by plant sterols such as stigmasterol and β-sitosterol toward the reduction of 520 cholesterol absorption. Surprisingly, HepG2 cells treated with these sterols showed simultaneous 521 down-regulation of NPC1L1 and SR-B1 when an opposite effect on these two molecules could be 522 expected. This modulation was not noticed when fungal sterols were applied to the hepatic cells 523 15 neither when administrated to mice together with a hypercholesterolemic diet 98 . Studies using 524 homozygous and heterozygous knockout mice (NPC1L1 -/-and NPC1L1 +/-) showed a lower 525 cholesterol absorption in homozygous animals however, heterozygous mice showed higher 526 HMGCR mRNA levels in gut and liver tissues than wild-type animals without changes in ABC 527 transporters expression rates. Authors explained their results by compensatory effects: difficulties 528 for cholesterol absorption were compensated by a stimulation of endogenous cholesterol 529 synthesis to maintain physiological plasma levels 101, 102 . Moreover, when the knockout mice were 530 treated with plant sterols or ezetimibe, the wild-type and heterozygous animals showed a 531 reduction in cholesterol and TG levels. Absorption of campesterol and β-sitosterol was reduced in 532
NPC1L1
+/-and almost absent in NPC1L1 -/-mice indicating that certain modulation of NPC1L1 took 533 place 101, 102 . However, no modulation of NPC1L1 expresion was noticed in C57BL/6 mice fed a fungal 534 sterol extract together with a hypercholesterolemic diet 98 . 535
Moreover, β-Sitosterol addition to Caco2 cultures induced down-regulation of HMGCR 536 expression although this effect was not noticed in mice. Only sitosterolemic individuals showed 537 reduction in HMGCR activity in ileum so apparently only large amounts of plan sterols or long-538 term 2% (w/w) plant sterol administration can induce such effect 11, 103 . 539
Other reports indicated that phytosterols might modulate the expression of other closely 540 related genes such as those encoding the hepatic cholesterelogenic farnesyl phosphate synthase 541 (FFPS), liver CYP7A1 (cytochrome P450 family 7 subfamily A polypeptide 1) or anexin 2-Caveolin 542 1 (ANXA2-CAV1) protein complex 11 . Therefore, fungal sterols might be involved in the modulation 543 of CYP7A1 noticed during the administration of the complete mushroom fruiting bodies to 544 hypercholesterolemic mice 90 . 545
Molecular events modulated by fungal polysaccharides
546
At the present, not many studies have been carried out concerning the molecular effect of 547 dietary fibers independly of their plant or fungal origen. However, already in 1996, Cheung reports 548 suggested that fungal polysaccharides extracts could modulate cholesterol related enzymesstudies were carried out to investigate the molecular role of fungal polysaccharides on cholesterol 551 metabolism 78 . 552 Fukushima et al. (2000) 104 examined the effects of a fiber extract obtained from Agaricus 553 bisporus on the LDLR mRNA expression after feeding rats with cholesterol-free diets during 4 554 weeks. Despite a higher relative liver weight in control group (cellulose supplementation) 555 comparing with those animals fed with the mushroom fiber extract as supplement, serum total 556 cholesterol, VLDL and LDL concentrations in the control group were significantly greater than 557 animals fed the A. bisporus fiber. Added to this, once LDLR mRNA hepatic levels were analyzed, 558 results showed that mushroom LDLR up-regulation was significantly higher than that induced by 559 cellulose fiber supplement 104 . One year later, the same group reported that maitake (Grifola 560 frondosa) and enokitake (Flammulina velutipes) fiber extracts lowered total serum cholesterol 561 levels by two mechanisms, by scavenging cholesterol molecules inducing their fecal excretion and 562 by enhancement of LDLR mRNA expression in rat liver 105 . However, no up-regulation was 563 significantly noticed when rats were fed shiitake (Lentinula edodes) fiber extracts. 564
Dietary fibres fractions from P. ostreatus, L. edodes and A. bisporus fruiting bodies obtained 565 as described by Jeurink et al. (2008) 106 including a low α-glucans amount and high concentrations 566 of chitin derivatives and other β-glucans 82 were also added to Caco2 cells to study their effect on 567 the most interesting cholesterol-related genes. The transcriptomic profile was studied after 1 and 568 24h application and results indicated that the fiber extracts obtained from P. ostreatus were able 569 of modulating transcription of more genes related to the cholesterol metabolism than the other 570 two mushroom studied at longer incubation times. Up-regulation of FDFT1 and NPC1L1 was 571 noticed together with slight modulation of a few others mRNAs therefore, in vivo experiments 572 were carried out using P. ostreatus fiber extract using two different experimental settings. In the 573 first one, C57BL/6J mice were firstly administrated hypercholesterolemic diets and then,Results indicated that their molecular responses were completely dependent on the 577 supplementation setting. In the palliative setting, administration of the fiber extract reduced 578 hepatic triglyceride levels and it might be because of the DGAT1 downregulation also recorded. In 579 the preventive setting, the fiber extract modulated cholesterol-related genes expression similarly 580 to simvastatin and ezetimibe in liver (i.e. by inhibiting FDFT1, NR1H3 (LXR) and NR1H4 (FXR) mRNA 581 expression) although no changes in plasma and liver biochemical data was recorded 107 . Later on, 582 when similar extract was applied in a higher concentration and mixed with lard, the 583 hypocholesterolemic effect was noticed (as reduction of TC and LDLc levels) but no relevant 584 modulation of cholesterol-related gene transcription was noticed despite overexpression of 585 NPC1L1 in mice liver and jejunum 98 . 586
The molecular modulations noticed for fungal β-glucans seemed to be different than other 587 Other studies indicated that the scavenging of bile acids by plant fiber (β-glucans) activated 602 CYP7A1 to convert cholesterol into new bile acids 108, 112 provoking an hepatic cholesterol decrease 603 that up-regulated LDLR expression and reduced cholesterol blood levels. Due to these changes, the 604 biosynthetic pathway was also activated via HMGCR up-regulation to compensate the lack of 605 hepatic cholesterol 112, 113 . However, the effect of fungal fibers on CYP7A1 is still at the present 606 unknown. 607
Other studies were carried out using extracts containing the water soluble 608 polysaccharides from L. edodes. This fraction contained α-and β-glucans and fucomannogalactans 609 that when digested (in vitro) were applied to Caco2 cell cultures and no significant effect was 610 noticed on the modulation of cholesterol-related gene expression. But, when the lower 611 compartment of the cell monolayer was applied to HepG2 modulation of some mRNAs were 612 noticed after 24h incubation. However, the modulatory pattern fitted more with a low cholesterol 613 level response since enzymes such as HMGCR, FDFT1 and ACAT1 were overexpressed, perhaps 614 the HMGCR inhibitory activity showed by this extract was inducing a posttranscriptional 615 cholesterol reduction that activated the biosynthetic pathway after 24h 114 . Later on, when this 616 extract was administrated to normocholesterolemic mice for 4 weeks similar overexpression of 617 HMGCR (in liver) and FDFT1 (in jejunum) were noticed. However, when the extract was 618 administrated to hypercholesterolemic mice the modulation profile showed similarities with 619 those generated after administration of ezetimibe, simvastatin or both such as for instance down-620 regulation of FDFT1 (in ileum), SREBF2 or NR1H4 (in jejunum) or up-regulation of ABCG8 or ACAT1 621 in jejunum. 622
Other polysaccharides extracted from 3 different strains of Pleurotus tuber-regium, when 623 administrated to obese-diabetic rats for 8 weeks, also showed and hypolipidemic effect that was 624 associated with up-regulated liver PPAR-alpha mRNA expression and protein levels. Moreover,restoration of decreased high-density lipoprotein (HDL) levels were noticed after their 628 supplementation 115 . 629
Molecular events modulated by other fungal compounds 630
An adenosine analogue alkaloid (eritadenine) is another compound from L. edodes able of 631 inhibiting the S-adenosylhomocysteine hydrolase, a key enzyme for the hepatic phospholipid 632 metabolism. This inhibition could be related to the lowering of cholesterol levels in serum noticed 633 in animal studies 116, 117 . Eritadenine increases the hepatic microsomal phosphatidylethanolamine 634 (PE) concentration and decreases the liver microsomal ∆6-desaturase activity, altering the fatty 635 acid and molecular species profile in liver and plasma. When it was administrated to rats, 636 suppression of 6-desaturase activity was accompanied by a significant reduction in the 637 abundance of mRNA for the enzyme suggesting that dietary eritadenine might suppress the activity 638 of liver microsomal 6-desaturase by altering the microsomal phospholipid profile and this effect 639 was mediated by the regulation of the enzyme transcription 118 . Eritadenine was also involved in 640 the up-regulation of the CYP7A1 expression noticed in liver of hypercholesterolemic mice fed the 641 standard compound or 5, 10 or 20 % L. edodes 119 . 642
Water extracts obtained by PWE (pressurized water extractions) from normal and selenium-643
enriched A. bisporus were tested in vitro as HMGCR inhibitors. Selenium supplementation 644 enhanced the inhibitory activity of statins and therefore, the latter extracts might improve their 645 HMGCR inhibitory capacity. However, no significant differences were found, they both similarly 646 inhibited the enzyme only if the extracts were not thermally treated. When the extracts were 647 applied to HepG2 cells to study their effect at the molecular level they also induced similar 648 responses in most of the cholesterol-related genes. However, after 1h application overexpression 649 of LDLR mRNA was noticed in non Se-fortified extracts. After 24h the LDLR mRNA was 650 downregulated together with the FDFT1. Similar downregulation of the SQS mRNA was also 651 noticed in Se-fortified extracts indicating that non-thermal water extracts from A. bisporus could 652 inhibit transcription of this enzyme that is also a key enzyme downstream the cholesterolmetabolic pathway 120 . Reduced expression of GPX3 (glutathione peroxidase, a selenoprotein 654 largely influenced by the presence of selenium in the media) was shown to increase cell-mediated 655 oxidation of LDL and selenium supplementation (1 ppm) also induced downregulation of APOB and 656 HMGCR expression during hypercholesterolemia in rat models. However, no significant 657 modulation of the GPX3 97 and APOB 120 expression was noticed neither in non-or Se-fortified 658 extracts only a slight up-regulation of HMGCR after 1h for non-fortified extracts and after 24h for 659
Se-fortified ones perhaps to compensate the inhibition of the FDFT1 transcription noticed 120 . 660
Conclusion
661
Consumption of edible mushrooms or functional foods containing specific fungal extracts 662 should be encouraged within people with low to moderate hypercholesterolemia (before the use 663 of pharmaceutical drugs) to lower their cholesterol levels in serum. As noticed for plants, cereals 664 and other food derivatives, they contain specific compounds that can modulate cholesterol 665 homeostasis via different transcriptional and post-traslational mechanisms that are nowadays, not 666 completely understood but that they could be different than those described for plants. Thus, 667 more studies are necessary to broad the knowledge toward the molecular effect of fungal 668 compounds on human health since the results obtained up to now are promising, suggesting that 669 their use as hypocholesterolemic foods might be more effective than those products actually 670 offered in the markets. 
